Addressing the Challenges of HPV Vaccination and Prevention
of HPV-related Cancers in Young and Older Adults

A continuing medical education activity sponsored by NAMCP and AAMCN

Addressing the Challenges of HPV Vaccination and Prevention of HPV-related Cancers in Young and Older Adults is a two-part webinar series focusing on the latest developments in the prevention of HPV-related cancers

These are archives of live webinars held between September 16 and September 18, 2020.
If you participated in any of the live webinars, you are not eligible to
claim credit from the archive of that webinar.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in all three or in order.

These activities are valid from October 1, 2020 to October 1, 2022


This series is supported by an educational grant from Merck Sharp & Dohme Corp.


 
Audience: This activity is intended for healthcare professionals practicing in managed care environments.

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

Description:
Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various types of cancer. An estimated 79 million people in the United States are infected with some type of HPV, and approximately 50% of new infections occur in individuals before the age of 24. Despite the availability of safe and effective vaccines, HPV vaccination coverage remains low. There are various reasons why the vaccination rates are low, including patients' and/or parents' lack of knowledge about HPV and their discomfort with talking to health care providers about sexual activity, affordability, among other reasons.


Addressing the Challenges of HPV Vaccination and Prevention of HPV-related Cancers in Young and Older Adults

  1. Identify perceived barriers by both healthcare providers and patients to HPV vaccination
  2. Identify disparities and barriers to HPV-associated cancer prevention across different patient populations
  3. Assess the efficacy, safety, and utility of HPV vaccination in children, adolescents, and adults
  4. Examine strategies to overcome barriers that impede successful completion of the HPV vaccination series
  5. Align current clinical practices with key HPV vaccination and cancer screening recommendations
       Physician, Nursing and CMCN credits valid to September 1, 2022

Addressing the Challenges of HPV Vaccination and Prevention of HPV-related Cancers: Managed Care Considerations and Updates

  1. Assess the latest clinical data regarding the impact of HPV vaccination on relevant clinical endpoints
  2. Identify key economic challenges surrounding HPV immunization in adolescents and adults and the need for more optimal medical intervention to reduce healthcare costs
  3. Apply methods to enable optimal cost management of vaccinations to be realized by multiple HPV stakeholders including managed care organizations
  4. Implement evidence-based managed care strategies for engaging providers and patients in shared decision-making on HPV vaccination
  5. Discuss the prevalence and burden of HPV-related cancers
       Physician, Nursing and CMCN credits valid to September 1, 2022